Respira Therapeutics
Phase 2Our advanced particle engineering and formulation approaches in combination with our proprietary device technologies are designed to enhance drug delivery to the lung periphery.
Founded
2013
Focus
Drug Delivery
About
Our advanced particle engineering and formulation approaches in combination with our proprietary device technologies are designed to enhance drug delivery to the lung periphery.
Funding History
2Total raised: $12.5M
Series A$10MUndisclosedJun 15, 2020
Seed$2.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2013
LocationAlbuquerque, United States
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile